China & Moderna

China: Sent a third medical expert team to DRC, strengthening bilateral cooperation and global health engagement.

Moderna: Authorized to begin Phase 1 trials for a Bundibugyo vaccine, using mRNA technology. Potential for significant revenue if successful.

China: China ranks fourth in the number of immigrant founders of US billion-dollar companies.

Moderna: Moderna is an immigrant-founded unicorn company that has gone public since 2016.

China: China>>> is developing an mRNA vaccine that has shown promise against Uganda — Bundibugyo in mice and has pledged to send medical specialists to the Democratic Republic of the Congo>>> to assist with the outbreak.

Moderna: Moderna is one of the entities developing an experimental vaccine for the Bundibugyo virus, which could lead to future revenue and enhance its reputation in vaccine development.

China: China has announced it will send a team of medical specialists to the Democratic Republic of the Congo to assist with the Ebola outbreak.

Moderna: Moderna is utilizing its mRNA technology to develop a vaccine for the Bundibugyo strain of Ebola, with funding from CEPI, aiming to rapidly train the body to fight the virus.

China: China is a major buyer of Gulf oil and has diplomatic influence. It benefits from discounted Iranian oil but avoids military involvement.

Moderna: Moderna is a pharma company, not directly affected.